MAALOX PLUS

200/175/25 MG/5ml Oral Suspension

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/109/001

Marketing Status

19 May 2015 - 22 Mar 201622 Mar 2016 - 15 Feb 2017
MarketedTemporarily Not Marketed
« Back

Latest Changes to Medicine Info & SPC


Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.